Tanaka Rie, Kawamura Maiko, Ito Michiho, Kikura-Hanajiri Ruri
Division of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-Ku, Kawasaki, Kanagawa, 210-9501, Japan.
Forensic Toxicol. 2025 Apr 3. doi: 10.1007/s11419-025-00718-3.
Recently, numerous lysergic acid diethylamide (LSD) analogs have emerged as designer drugs globally. These compounds are mainly distributed as sheet products. In this study, two new LSD analogs were identified from sheet products.
The structures of the compounds were determined by gas chromatography-mass spectrometry, liquid chromatography-photodiode array-mass spectrometry, liquid chromatography with hybrid quadrupole time-of-flight mass spectrometry and nuclear magnetic resonance (NMR) measurement.
From the NMR analysis, two compounds in the products were identified as N,N-diethyl-7-methyl-4-(3-(trimethylsilyl)propanoyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (1S-LSD) and 7-allyl-N,N-diethyl-4-(thiophene-2-carbonyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (1T-AL-LAD). In the product where 1S-LSD was detected, the presence of a trace amount of iso-1S-LSD, a C8-epimerization product of 1S-LSD, was suggested.
This paper is the first to report the detection of 1S-LSD and 1T-AL-LAD in sheet products in Japan. Notably, the metabolic pathways and biological activities of 1S-LSD and 1T-AL-LAD are not explored. The possibility of the in vivo deacylation and conversion of the compoundsinto LSD or AL-LAD should be further investigated.
近来,大量麦角酸二乙酰胺(LSD)类似物作为新型毒品在全球出现。这些化合物主要以片状产品形式流通。本研究从片状产品中鉴定出两种新型LSD类似物。
通过气相色谱 - 质谱联用、液相色谱 - 光电二极管阵列 - 质谱联用、液相色谱与混合四极杆飞行时间质谱联用以及核磁共振(NMR)测量来确定化合物的结构。
通过NMR分析,产品中的两种化合物被鉴定为N,N - 二乙基 - 7 - 甲基 - 4 - (3 - (三甲基甲硅烷基)丙酰基) - 4,6,6a,7,8,9 - 六氢吲哚并[4,3 - fg]喹啉 - 9 - 甲酰胺(1S - LSD)和7 - 烯丙基 - N,N - 二乙基 - 4 - (噻吩 - 2 - 羰基) - 4,6,6a,7,8,9 - 六氢吲哚并[4,3 - fg]喹啉 - 9 - 甲酰胺(1T - AL - LAD)。在检测到1S - LSD的产品中,提示存在痕量的异 - 1S - LSD,即1S - LSD的C8 - 差向异构化产物。
本文首次报道在日本的片状产品中检测到1S - LSD和1T - AL - LAD。值得注意的是,尚未探究1S - LSD和1T - AL - LAD的代谢途径及生物活性。这些化合物在体内脱酰基并转化为LSD或AL - LAD的可能性应进一步研究。